Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial

Overview of attention for article published in BMC Neurology, May 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Readers on

mendeley: 86 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 1,247 followers.

Efficacy of andrographolide in not active progressive multiple sclerosis: a prospective exploratory double-blind, parallel-group, randomized, placebo-controlled trial. https://t.co/DpNPucXLm0

11 May 2020

Reply Repost Favourite

New phase 2 trial for #progressiveMS https://t.co/pybRvBXwad

08 May 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.